Adaptive Biotechnologies
JP Morgan Healthcare Conference, Day 1: Guardant Health, Exact Sciences, Bruker, 10x Genomics, More
Highlights from the first day included Exact Sciences' profitability forecast, an update on QuidelOrtho's integration, and Guardant Health's "quantum leap forward" with its "smart" liquid biopsy platform.
New Products Posted to GenomeWeb: Thermo Fisher, Adaptive Biotech, Qiagen, Dolomite Bio, More
New products and services posted to GenomeWeb for the week of Nov. 28, 2022.
Adaptive Bio Narrows 2022 Revenue Guidance, Outlines Financial Expectations
Releasing Q3 results, the Seattle-based immune system biotechnologies firm set its new full-year revenue guidance to the range of $185 million to $190 million.
Adaptive Biotechnologies Inks Partnership to Integrate MRD Assay With Epic's EMR System
After the expected integration in 2023, providers can order Adaptive’s ClonoSeq assay and review the results using the Epic electronic medical record system.
Adaptive Biotechnologies Inks Financing Deal Worth up to $250M
The Seattle-based biotech company will receive the money in exchange for a percentage of its GAAP revenues.